Eosinophilic Gastroenteritis clinical trials at University of California Health
2 research studies open to eligible people
Learn How Well Dupilumab Works in Adult and Adolescent Participants With Eosinophilic Gastritis With or Without Eosinophilic Duodenitis and the Side Effects it May Have
open to eligible people ages 12 years and up
This study is researching an experimental drug called dupilumab. The study is focused on participants with active eosinophilic gastritis (EoG) with or without eosinophilic duodenitis (EoD). Participants with EoD only are not eligible for enrollment. …
at UCLA UCSF
OMEGA: Outcome Measures in Eosinophilic Gastrointestinal Disorders Across the Ages
open to eligible people ages 3 years and up
The purpose of this observational study is to find the best measures to define how well a person with eosinophilic disorder is doing. People with EoE, EoG, EoN and EoC normally undergo endoscopy and/or colonoscopy where cells are collected for…
at UCSD
Our lead scientists for Eosinophilic Gastroenteritis research studies include Guy A. Weiss, MD.
Last updated: